Exponent (EXPO) Aktienübersicht
Exponent, Inc. ist zusammen mit seinen Tochtergesellschaften als wissenschaftliches und technisches Beratungsunternehmen in den Vereinigten Staaten und international tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 3/6 |
| Künftiges Wachstum | 2/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 5/6 |
Belohnungen
Risikoanalyse
EXPO Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Exponent, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$60.83 |
| 52-Wochen-Hoch | US$81.95 |
| 52-Wochen-Tief | US$51.91 |
| Beta | 0.73 |
| 1 Monat Veränderung | 4.13% |
| 3 Monate Veränderung | -5.65% |
| 1 Jahr Veränderung | -17.97% |
| 3 Jahre Veränderung | -34.82% |
| 5 Jahre Veränderung | -32.98% |
| Veränderung seit IPO | 3,256.14% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jun 22
EXPO: AI Failure Analysis And Buybacks Will Support Premium Future P/E
Analysts have reduced their price target on Exponent to about $81.67 from $90, with recent target cuts to $80 citing macro uncertainty and a stronger preference for companies with resilient end markets and more visible growth drivers. Analyst Commentary Recent research on Exponent highlights a mix of optimism about the company’s positioning and caution around broader macro conditions, which is reflected in the reduced price targets around the US$80 level.
Narrativ-Update • Jun 07
EXPO: Resilient End Markets And Buybacks Will Support Future Earnings Quality
Analysts have reduced their price target on Exponent to $80 from $95, citing a preference for stocks with more resilient end markets and clearer growth drivers in the current small-cap industrials group. Analyst Commentary Recent research highlights that while the price target on Exponent has been adjusted to US$80 from US$95, the stock still sits on the preferred list within the smaller cap industrials group.Narrativ-Update • May 23
EXPO: Buybacks And Resilient End Markets Will Support Future Earnings Quality
Analysts have trimmed their fair value estimate for Exponent to $90 from $95, reflecting lower price targets in recent research and a stronger emphasis on selectivity in smaller cap industrials. Analyst Commentary Recent research points to a more selective stance on smaller cap industrials, with Exponent still viewed as a quality exposure for investors who prioritize resilient demand and clear growth drivers.Recent updates
Narrativ-Update • Jun 22
EXPO: AI Failure Analysis And Buybacks Will Support Premium Future P/E
Analysts have reduced their price target on Exponent to about $81.67 from $90, with recent target cuts to $80 citing macro uncertainty and a stronger preference for companies with resilient end markets and more visible growth drivers. Analyst Commentary Recent research on Exponent highlights a mix of optimism about the company’s positioning and caution around broader macro conditions, which is reflected in the reduced price targets around the US$80 level.Narrativ-Update • Jun 07
EXPO: Resilient End Markets And Buybacks Will Support Future Earnings Quality
Analysts have reduced their price target on Exponent to $80 from $95, citing a preference for stocks with more resilient end markets and clearer growth drivers in the current small-cap industrials group. Analyst Commentary Recent research highlights that while the price target on Exponent has been adjusted to US$80 from US$95, the stock still sits on the preferred list within the smaller cap industrials group.Narrativ-Update • May 23
EXPO: Buybacks And Resilient End Markets Will Support Future Earnings Quality
Analysts have trimmed their fair value estimate for Exponent to $90 from $95, reflecting lower price targets in recent research and a stronger emphasis on selectivity in smaller cap industrials. Analyst Commentary Recent research points to a more selective stance on smaller cap industrials, with Exponent still viewed as a quality exposure for investors who prioritize resilient demand and clear growth drivers.Seeking Alpha • May 04
Exponent: Rising Demand And A Reasonable Valuation Make It A Buy
Summary Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO’s fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price. Dividend safety is outstanding, supported by a conservative ~50% payout ratio, robust free cash flow, and no debt. Read the full article on Seeking AlphaNarrativ-Update • May 03
EXPO: AI Failure Analysis And Buybacks Will Support Higher Earnings Quality
Analysts have adjusted their view on Exponent with a modest change to the price target in the $5 range, reflecting updated assumptions on growth, profitability and a slightly higher future P/E multiple informed by recent mixed revisions from JPMorgan and UBS. Analyst Commentary Recent commentary around Exponent highlights a mix of caution and optimism, with price targets adjusted within a narrow range and opinions split on the risk and reward at current levels.Narrativ-Update • Apr 18
EXPO: AI Failure Analysis Demand Will Support Higher Earnings Quality
Analysts have adjusted the 12 month price target on Exponent to $95 from $90, reflecting updated assumptions around revenue growth, profit margins, and the P/E multiple they are willing to apply to future earnings. Analyst Commentary Recent Street research on Exponent has centered on how much investors are willing to pay for the company’s future earnings, with price targets adjusted as analysts revisit revenue assumptions, profit margins, and the P/E multiple.Narrativ-Update • Apr 04
EXPO: AI Failure Analysis Work Will Sustain Premium P/E And Shareholder Returns
Analysts have trimmed their average price target for Exponent by $1.67 to reflect slightly lower fair value and profit margin assumptions, while still applying a relatively high future P/E multiple informed by recent mixed price target moves from JPMorgan and UBS. Analyst Commentary Recent Street research on Exponent reflects a mix of optimism about the business model and caution around valuation and near term execution, which is why price targets have moved in both directions.Narrativ-Update • Mar 21
EXPO: AI Failure Analysis Work Will Support Margins And Shareholder Returns
Analysts have lifted their 12 month price target on Exponent by about $6 to around $92. This reflects updated expectations around revenue, margins and a slightly lower future P/E multiple following recent research updates from major firms.
Narrativ-Update • Mar 07
EXPO: Buybacks And Dividend Increases Will Support Future Shareholder Returns
Analysts nudged their price target on Exponent higher by $4, citing slightly firmer growth and margin assumptions, along with a modestly lower future P/E outlook as key supports for the revised view. Analyst Commentary Recent research coverage around Exponent has centered on how much investors should be willing to pay for the company relative to its growth and margin profile.Narrativ-Update • Feb 20
EXPO: Raised UBS Target And Buybacks Will Support Higher Future P/E
Analysts have raised their price target on Exponent by $4 to $85, citing updated assumptions that include slightly lower revenue growth, a modestly higher discount rate, improved profit margin expectations, and a higher future P/E multiple. Analyst Commentary Recent Street research around Exponent highlights a mix of optimism and restraint, with the latest published work focusing on valuation inputs, growth expectations, and how much investors are willing to pay for the stock through the P/E multiple.Analyseartikel • Feb 09
Exponent (NASDAQ:EXPO) Is Increasing Its Dividend To $0.31
The board of Exponent, Inc. ( NASDAQ:EXPO ) has announced that the dividend on 20th of March will be increased to...Narrativ-Update • Feb 06
EXPO: Bullish JPMorgan Initiation Will Support Confidence In Updated Fair Value Estimate
Analysts have raised their fair value estimate for Exponent from US$76.00 to US$81.00, citing updated assumptions for revenue growth, profit margins, and a slightly lower future P/E multiple in light of recent bullish Street research. Analyst Commentary Recent Street research, including a new bullish view from JPMorgan, has put more attention on how Exponent is priced and what could get in the way of the updated fair value estimate of US$81.00.Narrativ-Update • Jan 23
EXPO: AI Failure Analysis Work Will Offset Automation Headwind Risks
Analysts have trimmed their price target on Exponent to US$90 from US$100, citing both the potential for increased AI driven failure analysis work and the offsetting risk that greater automation could reduce billable hours in consulting. Analyst Commentary Recent research points to a more balanced view on Exponent, with the reduced US$90 price target reflecting both potential upside from AI driven work and execution risks around automation in core consulting practices.Narrativ-Update • Jan 09
EXPO: AI Failure Analysis Demand Will Support Future Consulting Engagements
Analysts have reduced their fair value estimate for Exponent to $90 from $100, citing a lower assumed future P/E multiple as they weigh the potential for AI-driven demand for failure analysis work against the risk that automation could reduce billable hours across the consulting sector. Analyst Commentary Recent commentary from bullish analysts centers on how AI adoption could shape Exponent's long term opportunity set, even as they factor in the risk that automation may cap billable hours across the consulting sector.Analyseartikel • Jan 08
What Exponent, Inc.'s (NASDAQ:EXPO) P/E Is Not Telling You
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 34.9x might make it look like a strong sell...Narrativ-Update • Dec 16
EXPO: AI Failure Analysis Demand Will Outweigh Automation Efficiency Headwinds
Analysts have nudged their fair value estimate for Exponent higher to approximately $85.50 from $83.00 per share, citing the potential for AI driven demand in complex failure analysis work, while acknowledging that automation related efficiency gains could temper billable hours across the consulting industry. Analyst Commentary Bullish analysts highlight that the revised target still implies meaningful upside from current levels, even after a modest trim.Narrativ-Update • Dec 01
EXPO: AI-Driven Demand Will Drive Future Engagements Despite Automation Headwinds
Analysts have revised Exponent's price target downward by $10 to $90 per share, citing potential opportunities from AI-driven engagements as well as industry headwinds related to automation efficiencies. Analyst Commentary Following the recent revision to Exponent's price target, analysts have highlighted both opportunities and risks facing the company in today's evolving market landscape.Narrativ-Update • Nov 17
EXPO: AI-Driven Client Demand Will Offset Automation Concerns In Consulting
Exponent’s analyst price target has been reduced by $10 to $90, as analysts cite ongoing automation concerns that could impact the consulting sector. They also note potential opportunities from increased AI-driven client demand.Analyseartikel • Nov 02
Exponent, Inc. Just Beat EPS By 8.5%: Here's What Analysts Think Will Happen Next
A week ago, Exponent, Inc. ( NASDAQ:EXPO ) came out with a strong set of third-quarter numbers that could potentially...Narrativ-Update • Nov 02
EXPO: Increased Buyback Will Drive Shareholder Returns In Coming Quarters
Narrative Update: Exponent Analyst Price Target Adjustment Analysts have lowered their price target for Exponent from $88 to $83. This change reflects updated expectations for revenue growth and profitability margins moving forward.Analyseartikel • Oct 06
Returns On Capital At Exponent (NASDAQ:EXPO) Have Stalled
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...Analyseartikel • Jul 30
A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$63.97 based on 2 Stage Free Cash Flow to Equity Exponent's US$70.44...Analyseartikel • Jul 14
When Should You Buy Exponent, Inc. (NASDAQ:EXPO)?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it received a lot of attention from a substantial...Analyseartikel • Jun 28
Exponent (NASDAQ:EXPO) Knows How To Allocate Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analyseartikel • May 27
Subdued Growth No Barrier To Exponent, Inc.'s (NASDAQ:EXPO) Price
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 36.7x might make it look like a strong sell...Analyseartikel • Apr 06
Is Exponent, Inc. (NASDAQ:EXPO) Potentially Undervalued?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it saw significant share price movement during...Analyseartikel • Mar 22
Return Trends At Exponent (NASDAQ:EXPO) Aren't Appealing
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Seeking Alpha • Mar 10
Exponent: A Unique Dividend Contender That Is Valued At A Premium
Summary Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership. Exponent's dividend safety is excellent, supported by a conservative payout ratio and robust free cash flow, but the current valuation is a concern. Read the full article on Seeking AlphaAnalyseartikel • Feb 13
Exponent's (NASDAQ:EXPO) Shareholders Will Receive A Bigger Dividend Than Last Year
Exponent, Inc.'s ( NASDAQ:EXPO ) dividend will be increasing from last year's payment of the same period to $0.30 on...Analyseartikel • Jan 30
Exponent, Inc.'s (NASDAQ:EXPO) Intrinsic Value Is Potentially 34% Above Its Share Price
Key Insights The projected fair value for Exponent is US$122 based on 2 Stage Free Cash Flow to Equity Exponent is...Analyseartikel • Dec 28
Risks To Shareholder Returns Are Elevated At These Prices For Exponent, Inc. (NASDAQ:EXPO)
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 42.7x might make it look like a strong sell...Analyseartikel • Dec 10
Here's What To Make Of Exponent's (NASDAQ:EXPO) Decelerating Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Nov 08
Exponent's (NASDAQ:EXPO) Earnings Seem To Be Promising
Despite posting healthy earnings, Exponent, Inc.'s ( NASDAQ:EXPO ) stock has been quite weak. Along with the solid...Analyseartikel • Oct 13
Estimating The Intrinsic Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$114 based on 2 Stage Free Cash Flow to Equity Current share price of...
Neues Narrativ • Aug 29
Operational Efficiency And Tactical Investments Set To Propel Future Profitability And Revenue Growth
Exponent's strategic management and operational efficiency improvements are poised to enhance future profitability and earnings potential.Analyseartikel • Aug 20
Exponent, Inc.'s (NASDAQ:EXPO) Share Price Not Quite Adding Up
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 51.1x might make it look like a strong sell...Aktionärsrenditen
| EXPO | US Professional Services | US Markt | |
|---|---|---|---|
| 7D | 6.9% | 1.4% | -2.6% |
| 1Y | -18.0% | -24.0% | 20.0% |
Rendite im Vergleich zur Industrie: EXPO übertraf die Branche US Professional Services , die im vergangenen Jahr eine Rendite von -24 erzielte.
Rendite vs. Markt: EXPO hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 20 erzielte.
Preisvolatilität
| EXPO volatility | |
|---|---|
| EXPO Average Weekly Movement | 4.6% |
| Professional Services Industry Average Movement | 7.6% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: EXPO hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: EXPODie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1967 | 1,013 | Catherine Corrigan | www.exponent.com |
Exponent, Inc. ist zusammen mit seinen Tochtergesellschaften als wissenschaftliches und technisches Beratungsunternehmen in den Vereinigten Staaten und international tätig. Das Unternehmen ist in zwei Segmenten tätig: Ingenieurwesen und andere wissenschaftliche Bereiche sowie Umwelt und Gesundheit. Es bietet Dienstleistungen in den Bereichen Biomechanik, biomedizinische Technik und Wissenschaften, Bauwesen und Hochbau, Bauberatung, Datenwissenschaften, Elektrotechnik und Informatik, menschliche Faktoren, Material- und Korrosionstechnik, Maschinenbau, Metallurgie und Korrosionstechnik, Polymer und Chemie, thermische Wissenschaften und Fahrzeugtechnik.
Exponent, Inc.'s Grundlagenzusammenfassung
| EXPO grundlegende Statistiken | |
|---|---|
| Marktanteil | US$2.95b |
| Gewinn(TTM) | US$108.93m |
| Umsatz(TTM) | US$551.14m |
27.1x
Kurs-Gewinn-Verhältnis 5.4x
Kurs-Umsatz-VerhältnisIst EXPO zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| EXPO Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$551.14m |
| Kosten der Einnahmen | US$357.50m |
| Bruttogewinn | US$193.64m |
| Sonstige Ausgaben | US$84.71m |
| Gewinn | US$108.93m |
Zuletzt gemeldete Gewinne
Apr 03, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 2.25 |
| Bruttomarge | 35.13% |
| Nettogewinnspanne | 19.76% |
| Schulden/Eigenkapital-Verhältnis | 0% |
Wie hat sich EXPO auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
2.0%
Aktuelle Dividendenrendite56%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/27 13:32 |
| Aktienkurs zum Tagesende | 2026/06/26 00:00 |
| Gewinne | 2026/04/03 |
| Jährliche Einnahmen | 2026/01/02 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Exponent, Inc. wird von 7 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Joseph Foresi | Brean Capital Historical (Janney Montgomery) |
| Alexis Huseby | D.A. Davidson & Co. |
| Tomohiko Sano | J.P. Morgan |